Compare Plaza Indonesia Realty Tbk. (PLIN) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Plaza Indonesia Realty Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Plaza Indonesia Realty Tbk. trades at Rp2,510 (market cap 8.91T), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Plaza Indonesia Realty Tbk. is far larger — about 85.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| PLIN | SCPI | |
|---|---|---|
Market Cap | 8.91T | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Plaza Indonesia Realty Tbk.
Plaza Indonesia (the Company) as shopping center, started the operational in 1990 which followed by the officially of the grand opening of five star hotel; Grand Hyaat Jakarta one year later. PT Plaza Indonesia Realty Tbk is the first company in Jakarta that integrated a five star hotel and a shopping center first class on one roof. In 1992, the Plaza Indonesia Realty, Tbk was succeeded to list the company on JSX and SSX. In 1994, the Company did “the right issue two-for-one” in order to increased the capital of Company.The Company is included in the business group of PT Bimantara Tbk, PT Paraga Artamida (Sinar Mas), PT Agung Ometraco Muda and PT Danaswara Utama.
Read more on PLIN →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
